# A Quarter the Odds of Being Offered It

By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-08-20 | Updated: 2026-10-27

Canonical page: https://glpwatchdog.org/research/a-quarter-as-likely-to-be-offered-it

> People with diabetes who also have a mental health diagnosis received worse care on almost every measure, and a quarter of the odds of being prescribed a GLP-1, while having half again the odds of being put on insulin.

## Key points

- Less general monitoring, HbA1c testing, retinal screening, lipid, renal and foot checks, each pooled from 11 to 29 studies.
- GLP-1 prescribing OR 0.26; insulin OR 1.52.
- But the 0.26 rests on TWO studies. The insulin finding (10 studies) carries the argument.
- This group is already gaining weight from antipsychotics, and insulin adds more.
- It also MEASURES the confounding this register has repeatedly inferred in observational studies.

A meta-analysis of 49 studies covering **5.5 million people with diabetes** found that those who also had a mental health diagnosis received worse diabetes care on almost every measure: less monitoring, fewer tests, and a quarter of the odds of being prescribed a GLP-1.[1] They did, however, have half again the odds of being put on insulin.

## What was measured

The review pooled cohort and case-control studies across Asia, North America, Europe and Australasia, covering 5,503,712 people with diabetes, of whom 838,366 (15.2%) had a diagnosed mental disorder. The comparison was the quality of diabetes care each group received, using standard monitoring indicators.

*Odds of receiving each element of diabetes care, with a mental disorder versus without. Below 1 means less likely.[1]*

| Care element | Odds ratio (95% CI) | Studies |
| --- | --- | --- |
| Any recommended monitoring | 0.81 (0.70–0.94) | 29 |
| HbA1c measurement | 0.81 (0.68–0.97) | 24 |
| Retinal screening | 0.77 (0.63–0.95) | 21 |
| Lipid and cholesterol measurement | 0.83 (0.69–0.99) | 20 |
| Renal investigation | 0.78 (0.63–0.96) | 16 |
| Foot examination | 0.85 (0.76–0.95) | 11 |
| **Insulin** | **1.52 (1.16–1.99)** | 10 |
| **GLP-1 receptor agonist** | **0.26 (0.13–0.49)** | **2** |

> **Read the last column beside the last row.** The GLP-1 figure is the most striking number in the table and rests on *two studies*. The monitoring findings each pool eleven to twenty-nine, and they are the robust part of this analysis. An odds ratio of 0.26 from two studies is a signal to act on, not a measurement to quote as settled.

The insulin finding carries the argument better. It rests on ten studies, with an odds ratio of 1.52, and it points the same way. This group gets the older drug and not the newer one.

## Why this is worse than it first appears

Consider what else is true of this population. Many are taking antipsychotics, and the most effective ones are the hardest on metabolism. [Clozapine and olanzapine drive weight gain](https://glpwatchdog.org/research/glp1-and-antipsychotic-weight-gain) and insulin resistance directly. Insulin itself causes weight gain. So the group being disproportionately prescribed insulin is the group already gaining weight from their psychiatric treatment.

> More likely to be given the drug that adds weight, less likely to be offered the one that removes it.

Nor does the treatment fail in them. A randomized trial of semaglutide added to clozapine or olanzapine improved blood sugar, weight and waist circumference with **no worsening of psychiatric symptoms** (see [antipsychotics and metabolic harm](https://glpwatchdog.org/research/antipsychotics-and-metabolic-harm)). There is evidence that it works in exactly these patients.

People with serious mental illness die substantially earlier than the general population, largely from cardiometabolic disease. This analysis describes the care that gap is built from, one missed test and one unoffered prescription at a time.

## The other thing this measures

> **We have argued repeatedly that observational studies of these drugs are confounded because they go to healthier, better-resourced patients while the sickest end up on insulin.** That argument has been an inference. This is one measurement of it: an odds ratio of 0.26 for receiving a GLP-1 and 1.52 for receiving insulin, in a group with markedly worse health.

That matters for reading almost every observational result on this register. When a claims-database study reports that GLP-1 users had far lower mortality than users of another diabetes drug, part of what it is measuring is documented here: the two groups were selected differently, along an axis that independently predicts dying.

The general problem is in [when a hazard ratio is too good](https://glpwatchdog.org/research/when-a-hazard-ratio-is-too-good), and what a study can do to earn trust despite it is in [how to trust an observational study](https://glpwatchdog.org/research/how-to-trust-an-observational-study). This paper supplies numbers that make the concern concrete.

## What it does not establish

- **It is association, not mechanism.** Whether the gap comes from clinician assumptions, from shorter appointments, from fragmented care between psychiatry and primary care, or from patients declining, is not separated here.
- **“Any mental disorder” covers a great deal**, from anxiety to schizophrenia to dementia, and the review reports subgroups separately for a reason.
- **Prescribing patterns change quickly**, and studies spanning years of a shifting market may already understate or overstate current practice.
- **Two studies is two studies.** The headline figure needs replication before anyone builds policy on its size.

The authors’ own conclusion is that addressing these disparities has the potential to address the excess mortality associated with mental disorders. That is a reasonable inference from an association, stated as a possibility rather than a finding.

## Frequently asked questions

### Are people with mental illness less likely to be prescribed a GLP-1?

A meta-analysis found odds of 0.26, roughly a quarter, for receiving a GLP-1 with a diagnosed mental disorder, though that figure comes from only two studies. The same analysis found odds of 1.52 for receiving insulin, from ten studies.

### What else differed in their care?

They were less likely to receive any recommended diabetes monitoring, HbA1c testing, retinal screening, lipid measurement, renal investigation or foot examination. Each finding pooled eleven to twenty-nine studies, and each pointed the same way.

### Why does the insulin finding matter?

Because insulin causes weight gain, and many in this group are also taking antipsychotics that cause weight gain. They are disproportionately given the drug that adds weight and not offered the one that removes it.

### Do these drugs work in people with serious mental illness?

Yes. A randomized trial of semaglutide added to clozapine or olanzapine improved blood sugar, weight and waist circumference with no worsening of psychiatric symptoms or psychiatric adverse events.

### How reliable is the 0.26 figure?

Less than the rest of the table. It rests on two studies, while the monitoring findings each pool eleven to twenty-nine. The direction is consistent with everything else in the analysis; the magnitude needs replication.

## References

1. Wagner E, Højlund M, Fiedorowicz JG, et al. Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysis. The Lancet Psychiatry. 2026. PMID: 41506273. https://pubmed.ncbi.nlm.nih.gov/41506273/

---

Cite as: GLP Watchdog, Nora Bissett, "A Quarter the Odds of Being Offered It", published 2026-08-20, updated 2026-10-27. https://glpwatchdog.org/research/a-quarter-as-likely-to-be-offered-it

Canonical HTML page: https://glpwatchdog.org/research/a-quarter-as-likely-to-be-offered-it

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
